Addiction

A new survey analysis shows prescription opioid, stimulant, sedative and tranquilizer misuse is common by age 50, and is greatly associated with substance abuse disorder risk.

Genetic evidence show increased alcohol intake may be a causal risk factor for GA, while increased lifetime smoking was associated with risk of advanced AMD.

The agent is administered through a single-dose, pre-filled syringe that delivers 5 milligrams through intramuscular or subcutaneous injection.

Results show an increase in methamphetamine use, methamphetamine use disorder, and overdose mortality.

Study shows single-session pain relief class noninferior to 8-session cognitive behavioral therapy for pain catastrophizing, pain intensity, and pain interference.

Dr. Marienfield discusses stigma as a major barrier in addiction treatment, as well as determining success based on patient goal.

Dr. Marienfield discusses therapy options for substance abuse patients in recovery.

Data show patients expected moderate improvements across all PCOQ domains with a median improvement range of 45% - 53.7%.

Data show 82% of studies reported significant abstinence from psychomotor stimulant use at the end-of-treatment assessment.

More than half of DAA prescriptions were prescribed by specialists like gastroenterologist and infectious disease physicians.

Data show skeletal muscle relaxant associated with increased risk of fall-related injury (OR 1.28) and all-cause hospitalization (OR 1.11).

Black patients received different opioid prescriptions compared to White patients, even after clinicians were given additional patient-level data.

A new study finds a 2-step chronic pain screening process helped identify patients in primary care with previously undocumented chronic pain.

Data show total amount of patients pre-guideline was 558,175 compared to 532,962 patients after the release of the guideline.

Data show 3 life-threatening adverse events required intervention, but were unrelated to buprenorphine induction.

Enrollees with OUD receiving medication treatment increased from 47.8% in 2014 to 57.1% in 2018

Physicians who performed well on ABIM examination less likely to prescribe opioids for back pain compared to physicians who did not perform well.

Data show pain scores were significantly lower in ibuprofen treatment group compared to acetaminophen.

Patient-reported scores showed no overall differences across 3- and 12- month follow-up.

Opioid prescription decreased substantially in 2 years following 2016 CDC guideline for prescribing opioids for chronic pain.

BUP associated with lower likelihood of any opioid use among participants with mood disorders, without mental disorder, compared to MET.

A discussion on the use of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic non-cancer pain and the implications for clinical practice.

Potential public health benefit of OAT linked to 50% lower risk of all-cause mortality.

Data show 1 in 5 surgical patients who receive prescriptions for benzodiazepine go on to use them persistently.

The reduction in heavy drinking in individuals between 18-25 years old is likely due to government restrictions on social gatherings.